Florence Mary

803 total citations
28 papers, 348 citations indexed

About

Florence Mary is a scholar working on Gastroenterology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Florence Mary has authored 28 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Gastroenterology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Florence Mary's work include Gastrointestinal motility and disorders (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastroesophageal reflux and treatments (5 papers). Florence Mary is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastroesophageal reflux and treatments (5 papers). Florence Mary collaborates with scholars based in France, Canada and United Kingdom. Florence Mary's co-authors include Robert Benamouzig, Michel Bouchoucha, Cyriaque Bon, Thomas Aparicio, Aziz Zaanan, Ghislain Devroede, Gheorghe Airinei, Thierry Lecomte, Pauline Afchain and Jean‐Baptiste Bachet and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Florence Mary

27 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Mary France 10 185 137 133 125 51 28 348
Jill E. Elwing United States 7 47 0.3× 47 0.3× 77 0.6× 64 0.5× 45 0.9× 21 301
Sajiv Sethi United States 10 154 0.8× 58 0.4× 41 0.3× 66 0.5× 15 0.3× 23 314
A S Mee United Kingdom 11 234 1.3× 57 0.4× 58 0.4× 169 1.4× 20 0.4× 21 357
Bruce Torrance United Kingdom 12 207 1.1× 110 0.8× 68 0.5× 53 0.4× 18 0.4× 30 308
Orestis Manousos Greece 7 77 0.4× 40 0.3× 116 0.9× 23 0.2× 54 1.1× 12 350
G Karácsony Hungary 10 141 0.8× 139 1.0× 64 0.5× 31 0.2× 26 0.5× 26 318
Wafi Attaallah Türkiye 10 251 1.4× 82 0.6× 167 1.3× 13 0.1× 8 0.2× 41 345
Francesco M. Serafini United States 10 320 1.7× 157 1.1× 131 1.0× 58 0.5× 6 0.1× 13 438
Hadi Razjouyan Iran 11 219 1.2× 40 0.3× 49 0.4× 216 1.7× 27 0.5× 13 340
Jae-Moon Bae South Korea 7 102 0.6× 213 1.6× 69 0.5× 112 0.9× 6 0.1× 9 315

Countries citing papers authored by Florence Mary

Since Specialization
Citations

This map shows the geographic impact of Florence Mary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Mary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Mary more than expected).

Fields of papers citing papers by Florence Mary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Mary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Mary. The network helps show where Florence Mary may publish in the future.

Co-authorship network of co-authors of Florence Mary

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Mary. A scholar is included among the top collaborators of Florence Mary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Mary. Florence Mary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brochériou, Isabelle, et al.. (2024). Thrombotic Microangiopathy After Long-Lasting Treatment by Gemcitabine: Description, Evolution and Treatment of a Rare Case. Journal of Medical Cases. 15(10). 272–277.
2.
Perkins, Géraldine, Astrid Pozet, David Tougeron, et al.. (2021). Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101709–101709. 3 indexed citations
3.
Tran‐Minh, My‐Linh, Jacqueline Lehmann‐Che, Jérôme Lambert, et al.. (2021). Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01. Clinics and Research in Hepatology and Gastroenterology. 45(4). 101691–101691. 15 indexed citations
4.
Aparicio, Thomas, Nathalie Cozic, Christelle de la Fouchardière, et al.. (2021). The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program. Targeted Oncology. 16(3). 381–388. 20 indexed citations
5.
Pernot, Simon, Karine Le Malicot, Florence Mary, et al.. (2020). Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302). Clinical Colorectal Cancer. 19(4). 285–290. 6 indexed citations
6.
Bouchoucha, Michel, et al.. (2020). Psychological profiles of irritable bowel syndrome patients with different phenotypes. Intestinal Research. 18(4). 459–468. 7 indexed citations
7.
8.
Bouchoucha, Michel, et al.. (2019). Clinical and psychological characteristics of patients with globus. Clinics and Research in Hepatology and Gastroenterology. 43(5). 614–622. 7 indexed citations
9.
10.
Bouchoucha, Michel, et al.. (2018). Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation. Digestive Diseases and Sciences. 63(7). 1763–1773. 23 indexed citations
11.
Pernot, Simon, Florence Mary, Karine Le Malicot, et al.. (2018). Aflibercept in combination with irinotecan, fluorouracil and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal cancer (mCRC) patients: A phase II multicentric study. Annals of Oncology. 29. viii160–viii160. 1 indexed citations
12.
Bachet, Jean‐Baptiste, Olivier Bouché, Julien Taı̈eb, et al.. (2017). RAS mutations concordance in circulating tumor DNA (ctDNA) and tissue in metastatic colorectal cancer (mCRC): RASANC, an AGEO prospective multicenter study.. Journal of Clinical Oncology. 35(15_suppl). 11509–11509. 8 indexed citations
13.
Mary, Florence, Nadezda Khodorova, Angélique Foucault‐Simonin, et al.. (2017). Metabolic markers of protein maldigestion after a15N test meal in minipigs with pancreatic exocrine insufficiency. American Journal of Physiology-Gastrointestinal and Liver Physiology. 314(2). G223–G230. 5 indexed citations
14.
Bouchoucha, Michel, et al.. (2017). Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?. Techniques in Coloproctology. 21(2). 125–132. 11 indexed citations
15.
Mary, Florence, Aziz Zaanan, Valérie Boige, et al.. (2016). Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study. Digestive and Liver Disease. 48(12). 1498–1502. 7 indexed citations
16.
Aparicio, Thomas, Aziz Zaanan, Florence Mary, et al.. (2016). Small Bowel Adenocarcinoma. Gastroenterology Clinics of North America. 45(3). 447–457. 34 indexed citations
17.
Landré, Thierry, Bernard Uzzan, Patrick Nicolas, et al.. (2015). Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis. International Journal of Colorectal Disease. 30(10). 1305–1310. 20 indexed citations
18.
19.
Aparicio, Thomas, Olivier Schischmanoff, Cécile Poupardin, et al.. (2014). High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer. Journal of Geriatric Oncology. 5(4). 384–388. 15 indexed citations
20.
Mary, Florence, et al.. (2014). Magnetic resonance imaging diffusion-weighted imaging for diagnosis of a gastric hepatoid adenocarcinoma. Digestive and Liver Disease. 47(2). 174–174. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill E. Elwing Breakdown of academic impact, for papers by Sajiv Sethi Breakdown of academic impact, for papers by A S Mee Breakdown of academic impact, for papers by Bruce Torrance Breakdown of academic impact, for papers by Orestis Manousos Breakdown of academic impact, for papers by G Karácsony Breakdown of academic impact, for papers by Wafi Attaallah Breakdown of academic impact, for papers by Francesco M. Serafini Breakdown of academic impact, for papers by Hadi Razjouyan Breakdown of academic impact, for papers by Jae-Moon Bae
Rankless by CCL
2026